A previous trial involving patients with metastatic prostate cancer that was resistant to androgen pathway modulation (formerly referred to as castration-resistant) showed that adding talazoparib ...
"Somewhere between 35-80% of people with PMOS experience insulin resistance, making weight management important." ...
The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...
Talazoparib plus enzalutamide reduces progression risk by 50% in men with DNA repair alter ...
Acne that won't go away. Hair thinning at the crown. Unwanted facial hair, unpredictable periods, mood swings and weight gain. For millions of women, these aren't just annoying symptoms—they're signs ...
Correspondence to Dr Angelica Lindén Hirschberg, Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm SE-17176, Sweden; angelica.linden-hirschberg{at}sll.se ...